Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury
Journal of Cardiobiology · 2024
DOI: 10.13188/2332-3671.1000026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiobiology, 2024. Verfasst von Lindon Young.
Abstract (Originalsprache)
Ischemia reperfusion (I/R); Left anterior descending (LAD); Left ventricular developed pressure (LVDP); Left ventricular end-diastolic pressure (LVEDP); Left ventricular enddiastolic volume (LVEDV); Left ventricular end-systolic pressure (LVESP); Left ventricular end-systolic volume (LVESV); Maximal rate of decrease in left ventricular pressure (dP/dt min ); Maximal rate of increase in left ventricular pressure (dP/dt max )., Myocardial infarction (MI); Myocardial Ischemia Reperfusion (MIR); Myristic acid (Myr) Myr-PKCε inhibitor (YT-001); Myr-Tat-PKCε inhibitor (YT-002); Nitric Oxide (NO); Protein Kinase C (PKC); Protein Kinase C Epsilon (PKCε); Pulmonary capillary wedge pressure (PCWP); Reactive Oxygen Species (ROS); Receptor for activated C kinase 1 (RACK1) Superoxide (SO); Tetrahydrobiopterin (BH 4 ); Transactivator of transcription (Tat); Tumor Necrosis Factor Alpha (TNFa).
Zitieren
APA
Young, L. (2024). Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury. Journal of Cardiobiology. https://doi.org/10.13188/2332-3671.1000026
Vancouver
Young L. Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury. Journal of Cardiobiology. 2024. doi:10.13188/2332-3671.1000026
BibTeX
@article{Young2024,
author = {Young, Lindon},
title = {Cell Permeable Protein Kinase C Epsilon Peptide Inhibitor Mitigates Myocardial Ischemic- Reperfusion Injury},
journal = {Journal of Cardiobiology},
year = {2024},
doi = {10.13188/2332-3671.1000026}
}
EUVIMED